Evidence map›Paper›PMID 40167912›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Cerebrospinal Fluid Phosphoproteome Characterization Using Titanium Dioxide Enrichment and High-Resolution LC-MS/MS.

Elena Anaya-Cubero, Adriana Cortés, Mercedes Lachén-Montes, Paz Cartas-Cejudo, Joaquín Fernández-Irigoyen, Enrique Santamaría

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena Anaya-CuberoClinical Neuroproteomics Unit, Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Adriana CortésClinical Neuroproteomics Unit, Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Mercedes Lachén-MontesClinical Neuroproteomics Unit, Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Paz Cartas-CejudoClinical Neuroproteomics Unit, Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Joaquín Fernández-IrigoyenClinical Neuroproteomics Unit, Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Enrique SantamaríaClinical Neuroproteomics Unit, Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain. esantamma@navarra.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebrospinal fluid (CSF) is a valuable source of biomarkers for neurological diseases due to its proximity to the central nervous system. Phosphorylation, a common post-translational modification, plays crucial roles in cellular signaling and is dysregulated in various neurological disorders.Analysis of the CSF phosphoproteome using titanium dioxide (TiO

Indexed as

Cerebrospinal Fluid ProteinsPhosphoproteinsProteomeProteomicsTandem Mass SpectrometryTitaniumBiomarkersChromatography, LiquidHumansLiquid Chromatography-Mass SpectrometryPhosphorylationBiomarkersCerebrospinal Fluid ProteinsPhosphoproteinsProteomeTitaniumtitanium dioxideCerebral fluid phosphopeptide enrichmentCSFLabel-freeLC-MS/MSMass spectrometryPhosphopeptidePhosphoproteomeProteomicsTitanium dioxide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.